SCHEMBL5865004

SCHEMBL5865004

N#Cc1cccc(/C=C/c2cccc(F)c2)n1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 1/20 0.57
NFE2L2 Q16236 10/20 0.55
RELA Q04206 2/20 0.50
KDM4E B2RXH2 1/20 0.50
NPC1 O15118 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
NFKB1 P19838 1/20 0.50
RAB9A P51151 1/20 0.50
NFKB2 Q00653 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
PTGS1 P23219 3/20 0.45
PTGS2 P35354 1/20 0.45
USP20 Q9Y2K6 1/20 0.44
NQO2 P16083 1/20 0.44
TRPV3 Q8NET8 1/20 0.40
HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5865007 1.00 GRM4 (0.57) GRM4NFE2L2RELAKDM4ENPC1
SCHEMBL5865235 0.84 GRM4 (0.50) GRM4NFE2L2KDM4ENPC1ALDH1A1
SCHEMBL5865233 0.84 GRM4 (0.50) GRM4NFE2L2KDM4ENPC1ALDH1A1
SCHEMBL4712459 0.82 GRM4 (0.56) GRM4KDM4ENPC1ALDH1A1HPGD
SCHEMBL4712457 0.82 GRM4 (0.56) GRM4KDM4ENPC1ALDH1A1HPGD
SCHEMBL5865152 0.82 RELA (0.45) GRM4RELAKDM4ENPC1ALDH1A1
SCHEMBL5865155 0.82 RELA (0.45) GRM4RELAKDM4ENPC1ALDH1A1
SCHEMBL5865061 0.81 CTSS (0.55) GRM4NFE2L2
SCHEMBL5865059 0.81 CTSS (0.55) GRM4NFE2L2
SCHEMBL5864986 0.78 CHAT (0.39) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034044-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2006-04-25 US disclosed
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER 2006-03-16 US disclosed
US-6951875-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2005-10-04 US disclosed
EP-1443926-A1 PYRIDINE DERIVATIVES AS NMDA-RECEPTOR SUBTYPE BLOCKERS F. HOFFMANN-LA ROCHE AG (CH) 2004-08-11 EP disclosed
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER (FR) 2004-04-08 US disclosed
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. 2003-07-31 US disclosed
WO-2003037333-A1 PYRIDINE DERIVATIVES AS NMDA-RECEPTOR SUBTYPE BLOCKERS F. HOFFMANN-LA ROCHE AG (CH) 2003-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C GRM4 20/4885NFE2L2 1274/4885RELA 1091/4885
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C GRM4 20/4885NFE2L2 1274/4885RELA 1091/4885
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN3A, GRIN2C GRM4 19/4885NFE2L2 1407/4885RELA 979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.